Inovio Pharma (INO) Posts Q4 Loss of 4c/Share; Offers Corp. Update

March 17, 2014 6:06 AM

Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q4 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found